CompanyCSL Behring GmbH
ATC codeB02BD
EU authorised2023-02-20
· 3 yr ago
Flags
Orphan
Conditional approval
EMA EPAR
Evidence dossier ↗
Hemgenix CONFIRMED
etranacogene dezaparvovec · Hemophilia
Current stage: 6 · first detected 2026-06-25
Also known as: hemgenix
Nordic decisions
| Country | Body | Verdict | Date | Source |
|---|---|---|---|---|
| Sverige | NT-rådet | använd inte | 2025-04-25 | link |
Status timeline
| Date | Body | Status | Stage | Source |
|---|---|---|---|---|
| No status history. | ||||